PEAK6 Investments’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

PEAK6 Investments’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,002	Closed	-$317K	–	4915
2023 Q4	$317K	Buy	1,002 +475	+90%	+$92.3K	﹤0.01%	2927
2023 Q3	$89.1K	Buy	+527	New	+$99.1K	﹤0.01%	3441
2023 Q2	–	Sell	-1,489	Closed	-$319K	–	4869
2023 Q1	$270K	Buy	+1,489	New	+$285K	﹤0.01%	2888

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

PEAK6 Investments's KRTX Position: Q1 2024 in Review

PEAK6 Investments sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 1,002 shares — an estimated $317K sold.

PEAK6 Investments first reported a position in KRTX in Q1 2023 and held it in 3 quarters. The position peaked at $317K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

PEAK6 Investments reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
PEAK6 Investments sold 1,002 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $317K.
PEAK6 Investments first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
PEAK6 Investments's Karuna Therapeutics, Inc. Common Stock position peaked at $317K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on PEAK6 Investments's 13F filing for Q1 2024, filed 14 May 2024.